Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed.

FIRST AMERICAN TREASURY OBLIGATIONS FUND CLASS Z- Performance charts including intraday, historical charts and prices and keydata.

FIRST AMERICAN GOVERNMENT OBLIGATIONS FUND CLASS X- Performance charts including intraday, historical charts and prices and keydata.